Cistron Biotechnology(CIST)$.30 Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rudy Saucillo who wrote (726)	6/14/1997 3:12:00 AM
From: scaram(o)uche	of 2742

I haven't had time to look in CIST materials yet, but the Techne 1996 annual report says that they funded the periodontal project in exchange for co-exclusive marketing rights. That means that, if the periodontal diagnostic was effective and if (that's two ifs) it addressed a large market (the posts here in the past two days are of interest), CIST would be sitting on a biggie. OK. It sort of seems that Bruce Galton is pretty good. Also, the EPR indicates that Hal Smith has also been straight with me. He indicated a long time ago that the company was taking its time so that the business plan would be a good one. So, from this stance, I'm sorry that I got ticked at these guys. On the other hand, I have not yet carefully reviewed the 10-Q, and there was stuff in it that bugged me, first time "lightly" through. When I think about some of the wording in the 10-Q and the Grausz mess, I am not at all sorry that I got ticked at these guys, and I get ticked all over again. Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next